---
title: 'Temp ğŸŠâ­'
date: 2023-01-03
permalink: /note/temp
tags:
  - note
toc: true
---

Essences of clinical medicine.

{% include toc %}

# Gastrointestinal / æ¶ˆåŒ–ç®¡

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

Esophageal atresia
Diaphragmatic hernia
Omphalocele
Gastroschisis
Ectopia
Meckel diverticulum
Pyloric stenosis
Hirschsprung disease

### Esophageal Disorders / é£Ÿé“ç–¾æ‚£
* **Esophageal obstruction**
  * Concept: Esophageal dysmotility, esophageal stenosis, esophageal mucosal web or ring
* **Achalasia**
  * Concept: Motility disorder of the esophagus characterized by incomplete lower esophageal sphincter relaxation and esophageal peristalsis loss
  * Pathogenesis: Degeneration of esophageal myenteric plexus (primary or secondary to Chagas disease)
  * Clinical: Dysphagia, regurgitation, chest pain
* **Laceration**
  * Concept: Longitudinal mucosal tears near gastroesophageal junction due to severe vomiting
    * Mallory-Weiss syndrome: Superficial tearing
    * Boerhaave syndrome: Transmural tearing
  * Clinical: Hematemesis following vomiting
{: .notice--info}


Chemical and infectious esophagitis
Reflux esophagitis
Eosinophilic esophagitis
Esophageal varices
Barrett esophagus
Adenocarcinoma
Squamous cell carcinoma


### Gastritis / èƒƒç‚
* **Acute gastritis / Gastropathy**
  * Concept: Inflammation of gastric mucosa (gastritis), epithelial damage (gastropathy)
  * Pathogenesis: Disruption of mucosal protection (NSAIDs, alcohol, bile reflux, stress)
  * Morphology: Intact epithelium, erosions, petechiae, hemorrhages
  * Clinical: Epigastric pain, nausea, vomiting, bleeding
* **Stree-related mucosal disease**
  * Concept: Gastropathy due to physical stress in critically ill patients
  * Pathogenesis: Mucosal injury from local ischemia (trauma, burns, intracranial disease)
  * Morphology: Erosion, perforation (often multiple)
  * Clinical: Asymptomatic, bleeding
* **Helicobacter pylori gastritis**
  * Concept: Chronic gastritis caused by Helicobacter pylori infection
  * Pathogenesis: H. pylori colonize mucosa, cause inflammation and atrophy
  * Morphology: H. pylori present, inflammatory infiltrate
  * Clinical: Asymptomatic, abdominal pain, peptic ulcer disease, gastric cancer
* **Autoimmune atrophic gastritis**
  * Concept: Chronic gastritis and atrophy caused by autoimmune
  * Pathogenesis: Antibody to parietal cells (defective acid production, hypergastrinema), antibody to intrinsic factor (vitamin B12 deficiency, pernicious anemia)
  * Morphology: Mucosal atrophy, loss of parietal cells, inflammatory infiltrate
  * Clinical: Anemia, neurological disturbances
* **Uncommon forms of gastritis**
  * Concept: Eosinophilic gastritis, lymphocytic gastritis, granulomatous gastritis
* **Peptic ulcer disease**
  * Concept: Chronic ulcer in stomach or duodenum
  * Pathogenesis: Imbalances between protective and damaging forces (H. pylori infection, NSAIDs)
  * Morphology: Punched-out defect, inflammation
  * Clinical: Epigastric pain, hemorrhage, perforation
{: .notice--info}

### Gastric Tumors / èƒƒè…«ç˜
* **Menetrier disease**
  * Concept: Giant hypertrophy of gastric rugae, protein loss from stomach
  * Pathogenesis: Excessive TGF-Î± production
  * Morphology: Gastric rugae enlargement, mucous cells hyperplasia, glandular atrophy
  * Clinical: Hypoproteinemia
* **Zollinger-Ellison syndrome**
  * Concept: Gastrin-secreting tumors cause excessive gastric acid secretion
  * Morphology: Gastric mucosal hypertrophy, peptic ulcers
  * Clinical: Severe peptic ulcers, diarrhea, possibly part of MEN1 
* **Inflammatory and hyperplastic polyps**
  * Concept: Common benign gastric polyps
  * Pathogenesis: Response to chronic gastritis (often H. pylori infection)
  * Morphology: Enlongated glands, inflammation
* **Fundic gland polyps**
  * Concept: Benign gastric polyps in fundus and body
  * Pathogenesis: PPI use, germline APC mutation (familial adenomatous polyposis)
  * Morphology: Cystically dilated fundic glands
* **Gastric adenoma**
  * Concept: Precancerous lesions that can progress to adenocarcinoma
  * Pathogenesis: Chronic gastritis with atrophy and intestinal metaplasia
  * Morphology: Polypoid lesions with low-grade or high-grade dysplasia
* **Gastric adenocarcinoma**
  * Concept: Malignant tumor from gastric epithelial cells
  * Pathogenesis: Associaged with H. pylori infection, dietary factors
    * Intestinal-type: Increased Wnt signaling (APC mutation)
    * Diffuse-type: E-cadherin loss (CDH1 mutation)
  * Morphology:
    * Intestinal-type: Glandular structures, bulky tumors
    * Diffuse-type: Discohesive signet-ring cells, linitis plastica
  * Clinical: Asymptomatic, epigastric pain, weight loss, hemorrhage
* **Lymphoma**
  * Concept: Lymphatic cancer in GI tract
  * Pathogenesis: Chronic inflammation (often H. pylori infection) induce MALT and cause gene translocation
  * Morphology: Stomach wall stickening, neoplastic lymphocytes infiltrates
  * Clinical: Epigastric pain, weight loss, hemorrhage
* **Neuroendocrine neoplasms**
  * Concept: Tumor from neuroendocrine cells in GI tract, vary from benign to malignant
  * Morphology: Uniform cells with salt and papper nucleus, well to poorly differentiated
  * Clinical: Asymptomatic, hormone production (Zollinger-Ellison syndrome, Carcinoid syndrome)
* **Gastrointestinal stromal tumor**
  * Concept: Tumor from interstitial cells of Cajal in GI tract
  * Pathogenesis: KIT mutation, PDGFRA mutation
  * Morphology: Well-circumscribed mass, spindle or epithelioid cells, CD117 positive
  * Clinical: Asymptomatic, mass effects, bleeding
{: .notice--info}

### Enterocolitis / è…¸ç‚
* **Cholera**
  * Concept: Vibrio cholerae infection leads to watery diarrhea
  * Pathogenesis: Cholera toxin binds to epithelial cells and causes excessive secretion of water and electrolytes
  * Morphology: Minimal changes (little inflammation)
  * Clinical: Watery diarrhea (rice-water stools), dehydration, shock
* **Campylobacter enterocolitis**
  * Concept: Campylobacter jejuni infection leads to enteritis
  * Pathogenesis: Motility, adherence, toxin production, invasion
  * Morphology: Inflammatory infiltrates, crypt abscesses
  * Clinical: Diarrhea (sometimes bloody), Guillain-Barre syndrome 
* **Shigellosis**
  * Concept: Shigella infection leads to dysentery
  * Pathogensis: Bacteria invade epithelial cells through M cells and cause inflammation, Shiga toxins inhibit protein synthesis and cause cell death
  * Morphology: Inflammatory infiltrates, hemorrhagic mucosa
  * Clinical: Diarrhea (watery and progress to bloody with mucus), abdominal cramps, fever
* **Salmonellosis**
  * Concept: Nontyphoid Salmonella infection leads to gastroenteritis
  * Pathogenesis: Bacteria invade through M cells and cause inflammation
  * Morphology: Inflammatory infiltrates
  * Clinical: Diarrhea, abdominal cramps, fever
* **Typhoid fever**
  * Concept: Salmonella typhi or paratyphi infection leads to systemic illness
  * Pathogenesis: Bacteria spread from intestine to bloodstream, leading to widespread inflammation
  * Morphology: Peyer patches enlargement, spleen enlargement, liver typhoid nodules
  * Clinical: Sustained fever, headache, constipation or diarrhea, rose spots, splenomegaly
* **Yersinia**
  * Concept: Yersinia enterocolitica infection leads to gastrointestinal symptoms
  * Pathogenesis: Bacterial invasion (in terminal ileum), iron enhances virulence
  * Morphology: Inflammatory infiltrates, lymph nodes enlargement
  * Clinical: Abdominal pain (mimicking appendicitis), diarrhea, fever, arthritis, erythema nodosum
* **Escherichia coli**
  * Concept: Pathogenic E. coli include enterotoxigenic E. coli, enteropathogenic E. coli, enterohemorrhagic E. coli, enteroinvasive E. coli, enteroaggregative E. coli
    * ETEC: Lead to traveler's diarrhea
    * EPEC: Lead to infantile diarrhea
    * EHEC: Lead to bloody diarrhea and hemolytic uremic syndrome (often O157:H7)
    * EIEC: Lead to watery to bloody diarrhea
    * EAEC: Lead to persistent diarrhea
  * Pathogenesis: 
    * ETEC: Heat-labile and heat-stable enterotoxins stimulate secretion of weter and electrolytes
    * EPEC: Adhere to epithelial cells and destruct microvilli (attaching and effacing lesions)
    * EHEC: Shiga toxins inhibit protein synthesis and cause cell death
    * EIEC: Bacteria invade epithelial cells through M cells and cause inflammation
    * EAEC: Adhere to epithelial cells (stacked brick morphology)
* **Pseudomembranous colitis**
  * Concept: Clostridioides difficile overgrowth following antibiotic use leads to persistent inflammation
  * Pathogenesis: Toxins disrupt mucosal cells
  * Morphology: Pseudomembranes composed of inflammatory cells and debris
  * Clinical: Watery diarrhea, abdominal pain, fever, toxic megacolon
* **Whipple disease**
  * Concept: Tropheryma whipplei infection leads to malabsorption
  * Pathogenesis: Bacteria-laden macrophages impair lymph drainage
  * Morphology: Accumulation of foamy macrophages filled with PAS-positive granules in lamina propria
  * Clinical: Diarrhea, weight loss, arthralgia
* **Viral gastroenteritis**
  * Concept:
    * Norovirus: Leading cause of gastroenteritis
    * Rotavirus: Leading cause of diarrhea in infants and young children
    * Adenovirus: Common cause of pediatric diarrhea
  * Clinical: Watery diarrhea, vomiting, fever
* **Parasitic enterocolitis**
  * Concept: Include nematodes (roundworms), trematodes (flukes), cestodes (tapeworms), protozoa
  * Pathogenesis:
    * Ascaris lumbricoides: Transmitted through ingestion of eggs, migrate to lung and mature in intestine
    * Strongyloides stercoralis: Transmitted through larvae penetration of skin, migrate to lung and mature in intestine, autoinfection
    * Hookworms: Include Necator duodenale and Ancylostoma duodenale, transmitted through larvae penetration of skin, migrate to lung and mature in intestine
    * Trichuris trichiura: Transmitted through ingestion of eggs, mature in intestine
    * Enterobius vermicularis: Transmitted through ingestion of eggs, mature in intestine
    * Schistosomiasis: Transmitted through larvae penetration of skin, mature in mesenteric veins
    * Intestinal cestodes: Include Diphyllobothrium latum & Taenia solium & Hymenolepis nana, transmitted through ingestion of larvae, mature in intestine
    * Entamoeba histolytica: Transmitted through ingestion of cysts, invade intestinal lining
    * Giardia lamblia: Transmitted through ingestion of cysts, colonize intestinal lining
    * Cryptosporidium: Transmitted through ingestion of oocysts, infect epithelial cells
  * Clinical:
    * Ascaris lumbricoides: Intestinal blockage, malnutrition, pneumonitis
    * Strongyloides stercoralis: Abdominal pain, diarrhea (disseminated infection in immunocompromised indivisuals)
    * Hookworms: Iron deficiency anemia, superficial erosions
    * Trichuris trichiura: (Heavy infections) Bloody diarrhea, rectal prolapse
    * Enterobius vermicularis: Anal itching (especially at night)
    * Schistosomiasis: Abdominal pain, diarrhea (bloody)
    * Intestinal cestodes: Asymptomatic, abdominal pain, diarrhea, vitamin B12 deficiency anemia (D. latum)
    * Entamoeba histolytica: Bloody diarrhea, liver abscess
    * Giardia lamblia: Diarrhea, fatty stools, abdominal cramps, malnutrition
    * Cryptosporidium: Watery diarrhea, abdominal pain (severe in immunocompromised individuals)
* **Irritable bowel syndrome**
  * Concept: Functional gastrointestinal disorder triggered by stress or food intakes without identidicable causes
  * Pathogenesis: Related with gut microbiome, GI sensitivity and motility, brain-gut interaction
  * Morphology: No specific endoscopic and microscopic changes
  * Clinical: Abdominal pain, bloating, changes in bowel habits (diarrhea or constipation)
* **Crohn disease**
  * Concept: Chronic inflammatory bowel disease affecting any part of GI tract, characterized by transmural inflammation
  * Pathogesis: Combination of immune dysregulation, host-microbe interactions, genetic predisposition
  * Morphology: Skip lesions, transmural inflammation, granulomas, fissures and fistulas, thickend walls and strictures
  * Clinical: Intermittent diarrhea (may be bloody) and abdominal pain, extraintestinal manifestations, colitis-associated neoplasia
* **Ulcerative colitis**
  * Concept: Chronic inflammatory bowel disease affecting colon and rectum, limited to mucosa and submucosa
  * Pathogesis: Combination of immune dysregulation, host-microbe interactions, genetic predisposition
  * Morphology: Continuous inflammation (from rectum), ulcers, pseudopolyps, mucosal atrophy
  * Clinical: Intermittent diarrhea (bloody) and abdominal pain, colitis-associated neoplasia
* **Indeterminate colitis**
  * Concept: Shows features of both Crohn disease and ulcerative colitis
* **Diversion colitis**
  * Concept: Inflammation of diverted colon segments following surgery, thought to result from lack of short-chain fatty acids
* **Microscopic colitis**
  * Concept: Includes collagenous colitis and lymphocytic colitis, characterized by chronic watery diarrhea with normal endoscopic appearances but distinctive histopathology
* **Graft-versus-host disease**
  * Concept: Gastrointestinal tract attacked by donor immune cells following allogeneic stem cell transplants
{: .notice--info}

### Intestinal Tumor / è…¸è…«ç˜
* **Hyperplastic polyps**
  * Concept: Benign epithelial proliferations
  * Pathogenesis: Abnormal epithelial cell turnover 
  * Morphology: Serration in upper parts of crypts
* **Inflammatory polyps**
  * Concept: Polyps resulting from recurrent inflammation and regeneration
* **Juvenile polyps**
  * Concept: Benign hamartomatous polyps typically found in rectum of children 
  * Pathogenesis: SMAD4 mutation, BMPR1A mutation
  * Morphology: Pedunculated polyps with smooth surfaces, cystic spaces filled with mucin
  * Clinical: Rectal bleeding, polyp prolapse, adenocarcinoma (juvenile polyposis syndrome)
* **Peutz-Jeghers syndrome**
  * Concept: Autosomal dominant syndrome with multiple hamartomatous
polyps and mucocutaneous hyperpigmentation
  * Pathogenesis: STK11 mutation
  * Morphology: Arborizing network of smooth muscles and glands
  * Clinical: Multiple gastrointestinal polyps, mucocutaneous hyperpigmentation on lips & oral mucosa & digits
* **Neoplastic polyps**
  * Concept: Precursors to colorectal adenocarcinoma
  * Pathogenesis: Adenoma-carcinoma sequence, microsatellite instability
  * Morphology:
    * Colorectal adenoma: Epithelial dysplasia, tubular or tubulovillous or villous
    * Sessile serrated lesion: Serrated crypts
  * Clinical: Asymptomatic, blood in stool
* **Familial adenomatous polyposis**
  * Concept: Autosomal dominant disorders characterized by hundreds to thousands of polyps and 100% risk of colorectal cancer
  * Pathogenesis: APC mutation, lead to activation of Wnt signaling and cellular proliferation
* **Hereditary non-polyposis colorectal cancer**
  * Concept: Autosomal dominant disorder with high risk of developing colorectal and other cancers (Lynch syndrome)
  * Pathogenesis: MSH2 or MLH1 (DNA mismatch repair gene) mutation, lead to microsatellite instability and accumulation of mutations
* **Adenocarcinoma**
  * Concept: Malignant tumor from colorectal epithelial cells
  * Pathogenesis:
    * Adenoma-carcinoma sequence: APC mutation, activation of Wnt signaling and cellular proliferation, KRAS and TP53 mutation
    * Microsatellite instability: MSH2 or MLH1 (DNA mismatch repair gene) mutation or hypermethylation, microsatellite instability, TGFBR2 or BAX mutation
  * Morphology: Well to poorly differentiated glands, occasionally with mucin and signet ring cells
  * Clinical: Blood in stool, abdominal pain, weight loss, fatigue
* **Anal tumors**
  * Concept: Most commonly squamous cell carcinoma
  * Pathogenesis: High-risk HPV infection from anal sex
* **Appendix tumors**
  * Concept:
    * Neuroendocrine tumor: Found in resected appendix
    * Adenoma / Adenocarcinoma: Can mimic acute appendicitis
    * Mucinous neoplasm: Can cause pseudomyxoma peritonei
* **Peritoneal tumors**
  * Concept:
    * Primary: Mesothelioma
    * Secondary: Metastases from gastric, colorectal, ovarian cancers
{: .notice--info}

### Other Intestinal Disorders / ãã®ä»–ã®è…¸ç–¾æ‚£
* **Diverticular disease**
  * Concept: Present of pouch-like protrusions of intestinal wall (common in sigmoid colon)
  * Pathogenesis: Result from increased intraluminal pressure and colon wall weaknesses, enhanced by low-fiber diet
  * Morphology: Herniations of mucosa and submucosa through muscular layer of colon wall
  * Clinical: Asymptomatic (diverticulosis), acute pain (diverticulitis)
* **Hernias**
  * Concept: Organs protrude through peritoneum pouch at weak spot of abdominal wall, include inguinal & femoral & umbilical, may cause obstruction
* **Adhesions**
  * Concept: Formation of fibrous bands between abdominal tissues and organs, from surgery or inflammation, may cause obstruction
* **Volvulus**
  * Concept: Loop of intestine twist around itself and mesentery, cause obstruction and infarction
* **Intussusception**
  * Concept: Segment of intestine fold into immediately distal segment, typically in infants and young children, cause obstruction and infarction
* **Ischemic bowel disease**
  * Concept: Insufficient blood flow to intestines lead to inflammation and injury, acute or chronic
  * Pathogenesis: Thrombosis (from atherosclerosis), emboli (from aortic atheromas or cardiac thrombi), hypoperfusion, venous thrombosis
  * Morphology: Edema, hemorrhage, mucosal atrophy, fibrosis (chronic)
  * Clinical: Abdominal pain, bloody diarrhea
* **Angiodysplasia**
  * Concept: Malformed and dilated blood vessels in GI tract (often in cecum and colon)
  * Pathogenesis: From intermittent obstruction of submucosal veins
  * Morphology: Ectatic nests of tortuous veins and capillaries
  * Clinical: Asymptomatic, intestinal bleeding
* **Cystic fibrosis**
  * Concept: Autosomal recessive disorder characterized thick mucus affecting various organs (lungs, pancreas, liver, GI tract)
  * Pathogenesis: CFTR mutation (defective chloride transport), thick mucus, pancreatic intraductal concretions, exocrine pancreatic insufficiency, impaired nutrient absorption
* **Celiac disease**
  * Concept: Autoimmune disorder triggered by ingestion of gluten in genetically predisposed individuals
  * Pathogenesis: Gluten exposure leads to inappropriate immune response (via HLA-DQ2 or HLA-DQ8), damaging small intestine's villi and impairing nutrient absorption
  * Morphology: Villous atrophy, crypt hyperplasia, increased intraepithelial lymphocytes
  * Clinical: Diarrhea, bloating, weight loss, anemia, extraintestinal manifestations (dermatitis herpetiformis)
* **Environmental enteric dysfunction**
  * Concept: Enteric disorder characterized by malabsorption in areas with poor sanitation
  * Pathogenesis: Defective intestinal barrier and transport functions secondary to chronic exposure to fecal pathogens
  * Clinical: Malabsorption, malnutrition, stunted growth
* **Autoimmune enteropathy**
  * Concept: X-linked disorder characterized by severe persistent diarrhea and autoimmune disease in young children
  * Pathogenesis: Defective regulatory T cells, autoantibodies to intestinal epithelial cells
* **Lactase deficiency**
  * Concept: Inability to digest lactose
  * Pathogenesis: Low levels of lactase enzyme, congenital or acquired
  * Clinical: Bloating and diarrhea after ingesting lactose-containing foods
* **Microvillus inclusion disease**
  * Concept: Autosomal recessive disorder causing intractable diarrhea in infancy due to abnormal enterocyte microvillus
  * Morphology: Microvillus inclusions
* **Abetalipoproteinemia**
  * Concept: Autosomal recessive disorder characterized by inability to absorb fats and fat-soluble vitamins
  * Pathogenesis: MTP mutation, impaired assembly and secretion of apolipoprotein B-containing lipoproteins
  * Morphology: Large lipid droplets in enterocytes
  * Clinical: Failure to thrive, diarrhea, steatorrhea
* **Hemorrhoids**
  * Concept: Swollen vascular structures in anal cacal
  * Pathogenesis: Elevated pressure in hemorrhoidal plexus (chronic constipation, pregnancy, portal hypertension)
  * Clinical: Pain, rectal bleeding
* **Acute appendicitis**
  * Concept: Acute inflammation of the appendix
  * Pathogenesis: Luminal obstruction by fecalith or lymphoid hyperplasia, lead to ischemia and inflammation
  * Morphology: Transmural inflammation, suppuration, gangrene
  * Clinical: Abdominal pain (periumbilical first, at RLQ McBurney's point later), nausea, vomiting, fever, peritonitis (when perforated)
* **Peritonitis**
  * Concept: Inflammation of peritoneum
  * Pathogenesis: GI tract perforation, cirrhosis and ascites (spontaneous bacterial peritonitis), dialysis
  * Morphology: Neutrophil infiltration, fibrinopurulent debris
  * Clinical: Severe abdominal pain, tenderness, distension, fever, nausea, vomiting
* **Sclerosing retroperitonitis**
  * Concept: Fibrosis across retroperitoneal space, compressing retroperitoneal structures
  * Pathogenesis: IgG4-related sclerosing disease
{: .notice--info}

### Hepatitis / è‚ç‚
* **Viral hepatitis**
  * Concept: Liver damages caused by hepatotropic viruses
    * Hepatitis A: Acute hepatitis, acute liver failure
    * Hepatitis B: Acute hepatitis, acute liver failure, chronic hepatitis
    * Hepatitis C: Chronic hepatitis
    * Hepatitis D: Acute liver failure (dependent on HBV)
    * Hepatitis E: Acute hepatitis
  * Pathogenesis: 
    * Hepatitis A: Fecal-oral transmission
    * Hepatitis B: Blood transmission, sexual transmission, mother-to-child transmission
    * Hepatitis C: Blood transmission
    * Hepatitis D: Co-infection with HBV
    * Hepatitis E: Fecal-oral transmission
  * Morphology: 
    * Acute hepatitis: Portal inflammation, hepatocellular injury
    * Chronic hepatitis: Portal inflammation and fibrosis   
  * Clinical:
    * Acute hepatitis: Fever, fatigue, jaundice
    * Chronic hepatitis: Asymptomatic, biochemical and serologic evidence
* **Autoimmune hepatitis**
  * Concept: Chronic progressive hepatitis associated with autoimmune
  * Pathogenesis: Viruses or drugs trigger immune reaction, associated with specific HLA alleles
  * Morphology: Inflammation, hepatocellular injury
  * Clinical: Progress to cirrhosis 
* **Drug-induced liver injury**
  * Concept: Liver damage caused by drugs (eg. acetaminophen)
  * Pathogenesis: Injury mediated by drug metabolites through cytochrome P-450
  * Morphology: Inflammation, hepatocellular injury
  * Clinical: Abnormal live function test
* **Alcoholic liver disease**
  * Concept: Liver damage caused by long-term alcohol comsumption
  * Pathogenesis: Increased NADH (steatosis), acetaldehyde and ROS (hepatocyte injury)
  * Morphology:  Steatosis, lobular inflammation, ballooned hepatocytes, fibrosis
  * Clinical: Asymtomatic (steatosis), malaise and abnormal lab findings (hepatitis), hepatic dysfunction (cirrhosis)
* **Nonalcoholic fatty liver disease**
  * Concept: Fatty liver independent of alcohol, associated with metabolic syndrome
  * Pathogenesis: Unknown, insulin resistance related
  * Morphology: Steatosis, lobular inflammation, ballooned hepatocytes, fibrosis
  * Clinical: Asymptomatic
* **Acute liver failure**
  * Concept: Acute dysfunction of normal liver
  * Pathogenesis: Viral hepatitis, drug-induced liver injury
  * Morphology: Massive hepatic necrosis
  * Clinical: Cholestasis, hepatic encephalopathy, coagulopathy
* **Chronic liver failure / Cirrhosis**
  * Concept: Advanced fibrosis in chronic liver diseases
  * Pathogenesis: Viral hepatitis, autoimmune hepatitis, alcoholic liver disease, nonalcoholic fatty liver disease
  * Morphology: Nodules surrounded by fibrosis
  * Clinical:
    * Impaired synthesis: Edema (albumin), coagulopathy (clotting factors)
    * Impaired metabolism: Jaundice (bilirubin), palmar erythema & spider angiomas & gynecomastia (estrogen), hepatic encepalopahty (ammonia)
    * Portal hypertension: Ascites, caput medusa, esophageal varices, splenomegaly
{: .notice--info}

### Hepatic Tumors / è‚è…«ç˜
* **Focal nodular hyperplasia**
  * Concept: Benign non-neoplastic lesion
  * Pathogenesis: Altered blood flow leads to hepatocytes hyperplastic changes
  * Morphology: Central stellate scar
  * Clinical: Asymptomatic
* **Cavernous hemangioma**
  * Concept: Most common benign liver tumor
  * Morphology: Dilated vascular channels
* **Hepatocellular adenoma**
  * Concept: Benign tumor associated with oral contreceptive and anabolic steriods
  * Pathogenesis: HNF1Î±-inactivated, inflammatory, Î²-catenin-activated
  * Morphology: Tumor without portal tracts
  * Clinical: Rupture or malignant transformation
* **Hepatoblastoma**
  * Concept: Most common malignant liver tumor of early childhood
  * Pathogenesis: Activation of Wnt signaling pathway
  * Morphology: Epithelial type, mixed type
  * Clinical: Abdominal swelling
* **Hepatocellular carcinoma**
  * Concept: Malignant liver tumor from hepatocytes, associated with chronic liver diseases (HBV, HCV, alcoholic)
  * Pathogenesis: Chronic injury, inflammation, and regeneration lead to acquisition of driver mutations 
  * Morphology: Sheets or trabeculae of tumor cells resembling normal hepatocytes
  * Clinical: Abdominal pain and fatigue (nonspecific), jaundice and ascitis (progressed)
* **Metastatic liver tumor**
  * Concept: Metastasis from colon, pancreas, lung, breast, etc.
{: .notice--info}

### Other Liver Disorders / ãã®ä»–ã®è‚è‡“ç–¾æ‚£
* **Hemochromatosis**
  * Concept: Excessive iron deposition in liver, pancreas, heart
  * Pathogenesis:
    * Hereditary: HFE mutation
    * Secondary: Red cell transfusion
  * Morphology: Hemosiderin deposition
  * Clinical: Hepatomegaly and cirrhosis, diabetes mellitus, cardiac dysfunction, skin pigmentation
* **Wilson disease**
  * Concept: Copper deposition in liver, basal ganglia, cornea
  * Pathogenesis: ATP7B mutation impair copper excretion into bile amd incorporation into ceruloplasmin
  * Morphology: Varied liver damage
  * Clinical: Liver dysfunction, extrapyramidal symptoms, Kayser-Fleischer ring
* **Î±1-Antitrypsin deficiency**
  * Concept: Protein folding disorder with low circulating Î±1-Antitrypsin
  * Pathogenesis: Uninhibited elastase (pulmonary emphysema), misfolded protein accumulation (liver disease)
  * Morphology: Cytoplasmic globular inclusions
  * Clinical: Cirrhosis, pulmonary emphysema
* **Hereditary hyperbilirubinemia**
* **Primary hepatolithiasis**
* **Hepatic vein thrombosis**
* **Sinusoidal obstruction syndrome**
* **Preeclampsia / Eclampsia**
* **Acute fatty liver of pregnancy**
{: .notice--info}

### Biliary Disorders / èƒ†é“ç–¾æ‚£
* **Extrahepatic biliary atresia**
* **Choledochal cyst**
* **Fibropolycystic disease**
* **Cholelithiasis**
  * Concept: Stones formed in biliary tract
  * Pathogenesis:
    * Cholesterol stones: Cholesterol monohydrate, caused by cholesterol supersaturation in bile
    * Pigment stones: Bilirubin calcium, caused by hemolytic anemia or bacterial infections
  * Morphology:
    * Cholesterol stones: Pale yellow, radiating palisade
    * Pigment stones: Brown to black, laminated
  * Clinical: Asymptomatic, colicky pain after meals
* **Acute cholecystitis**
  * Concept: Acute inflammation of gallbladder
  * Pathogenesis: Gallstones obstruction, superimposed bacterial infections
  * Morphology: Thickened walls, cloudy bile
  * Clinical: Fever, RUQ pain, jaundice
* **Chronic cholecystitis**
  * Concept: Chronic inflammation of gallbladder
  * Pathogenesis: Gallstones (obstruction not required)
  * Morphology: Inflammation, Rokitansky-Aschoff sinuses
  * Clinical: Recurrent colicky pain
* **Primary biliary cholangitis**
* **Primary sclerosing cholangitis**
* **Gallbladder carcinoma**
  * Concept: Malignant tumor from gallbladder
  * Pathogenesis: Gallstones
  * Morphology: Adenocarcinoma, glandular structures
  * Clinical: Pain, jaundice
* **Malignant biliary tumors**
  * Concept: Malignant tumor from intrahepatic biliary tree (intrahepatic cholangiocarcinoma) or extrahepatic bile duct (biliary adenocarcinoma)
  * Pathogenesis: Chronic inflammation of bile ducts (hepatolithiasis, primary sclerosing cholangitis, liver fluke infection)
  * Morphology: Adenocarcinoma, glandular structures
  * Clinical: Asymptomatic (intrahepatic), obstructive jaundice (extrahepatic)
{: .notice--info}

### Pancreas Disorders / è†µç–¾æ‚£
{: .notice--info}

Congenital anomaly
Acute pancreatitis
Chronic pancreatitis
Congenital cyst
Pseudocyst
Cystic Neoplasm
Pancreatic carcinoma
Acinar cell carcinoma
Pancreatoblastoma


## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Esophageal Disorders / é£Ÿé“ç–¾æ‚£

## Gastric and Duodenal Disorders / èƒƒãƒ»åäºŒæŒ‡è…¸æ½°ç˜

## Intestine and Anal Disorders / è…¸ãƒ»è‚›é–€ç–¾æ‚£

## Diaphragm and Abdominal Wall Disorders / æ¨ªéš”è†œãƒ»è…¹å£ç–¾æ‚£

## Liver Disorders / è‚ç–¾æ‚£

## Biliary System Disorders / èƒ†é“ç³»ç–¾æ‚£

## Pancreas Disorders / è†µç–¾æ‚£

# Cardiovascular / å¾ªç’°å™¨

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

### å¿ƒä¸å…¨
Left-sided heart failure
Right-sided heart failure

### Ischemic Heart Disease / è™šè¡€æ€§å¿ƒç–¾æ‚£
Angina pectoris
Myocardial infarction
Chronic ischemic heart disease
Sudden cardiac death

### Valvular Heart Disease / å¼è†œç—‡
Calcific aortic stenosis
Calcific stenosis of congenitally bicuspid aortic valve
Mitral annular calcification
Mitral valve prolapse
Rheumatic heart disease
Infective endocarditis
Nonbacterial thrombotic endocarditis
Endocarditis of systemic lupus erythematosus
Carcinoid heart disease
Complications of prosthetic valves

### Cardiomyopathy / å¿ƒç­‹ç—‡
Dilated cardiomyopathy
Arrhythmogenic cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Myocarditis

### Pericardial Disease / å¿ƒè†œç–¾æ‚£
Pericardial effusion
Acute pericarditis
Chronic pericarditis

### Cardiac Tumor / å¿ƒè‡“è…«ç˜
Myxoma
Papillary fibroelastoma
Rhabdomyoma
Metastatic tumor

### Congenital Heart Disease / å…ˆå¤©æ€§å¿ƒç–¾æ‚£
Atrial septal defect
Patent foramen ovale
Ventricular septal defect
Patent ductus arteriosus
Tetralogy of fallot
Transposition of the great arteries
Tricuspid atresia
Coarctation of the aorta
Pulmonary stenosis and atresia
Aortic stenosis and atresia

### Hypertension / é«˜è¡€åœ§
Hypertension
Systemic hypertensive heart disease
Pulmonary hypertensive heart disease

### Arteriosclerosis / å‹•è„ˆç¡¬åŒ–ç—‡
Arteriolosclerosis
MÃ¶nckeberg medial sclerosis
Fibromuscular intimal hyperplasia
Atherosclerosis


Vascular anomaly

### Vascular Tumors / è¡€ç®¡è…«ç˜
Vascular ectasias
Hemangioma
Lymphangioma
Glomus tumor
Bacillary angiomatosis
Kaposi sarcoma
Hemangioendothelioma
Angiosarcoma

### Arteritis / å‹•è„ˆç‚
Giant cell arteritis
Takayasu arteritis
Polyarteritis nodosa
Kawasaki disease
Buerger disease
Granulomatosis with polyangiitis
Eosinophilic granulomatosis with polyangiitis
Microscopic polyangiitis
IgA vasculitis
Infectious vasculitis

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Ischemic Heart Disease / è™šè¡€æ€§å¿ƒç–¾æ‚£

## Valvular Heart Disease / å¿ƒå¼è†œç—‡

## Endocardium, Myocardium, and Pericardium Disorders / å¿ƒå†…è†œãƒ»å¿ƒç­‹ãƒ»å¿ƒè†œç–¾æ‚£

## Arrhythmia / ä¸æ•´è„ˆ

## Arterial Disorders / å‹•è„ˆç–¾æ‚£

## Venous Disorders / é™è„ˆç–¾æ‚£

## Blood Pressure Abnormalities / è¡€åœ§ç•°å¸¸

# Respiratory / å‘¼å¸å™¨

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

### Infectious Diseases / æ„ŸæŸ“æ€§ç–¾æ‚£
* **Bacterial pneumonia**
  * Concept: Lung bacterial infection. Can be community-acquired (often after viral infection), health care-associated, hospital-acquired, aspiration
    * Streptococcus pneumoniae: Commonly cause community-acquired pneumonia
    * Haemophilus influenzae: Commonly cause community-acquired pneumonia and COPD acute exaceberation
    * Moraxella catarrhalis: Commonly cause COPD acute exaceberation
    * Staphylococcus aureus: High incidence of complication
    * Klebsiella pneumoniae: Commonly infect debilitated patients
    * Pseudomonas aeruginosa: Commonly cause hospital-acquired pneumonia
    * Legionella pneumophila: Transmitted in artificial aquatic environments, may be severe
    * Mycoplasma pneumoniae: Commonly infect children and young adults
  * Morphology:
    * Lobar pneumonia: Entire lobe consolidation. Congestion, red hepatization, gray hepatization, resolution
    * Bronchopneumonia: Patchy consolidation
  * Clinical: Cough with sputum, fever
* **Viral pneumonia**
  * Concept: Lung viral infection
    * Influenza virus: Influenza A can cause pneumonia or subsequent bacterial pneumonia
    * Human coronavirus: SARS-CoV-2 can cause severe or fatal pneumonia
  * Morphology: Interstitial inflammation involving alveolar walls
  * Clinical: Fever, cough (may be absent)
* **Lung abscess**
  * Concept: Suppurative disease of lung
  * Pathogenesis: Aspiration of pathogens, antecedent lung infection
  * Morphology: Abscesses, cavitation
  * Clinical: Cough, fever, foul-smelling sputum
* **Chronic pneumonia**
  * Concept: Granulomatous infection of lung
    * Mycobacterium
    * Histoplasma
    * Blastomyces
    * Coccidioides
  * Morphology: Granulomas, yeasts 
  * Clinical: Resolve spontaneuously or progress
* **Pneumonia in immunocompromised host**
  * Concept: Opportunistic infections in immonocompromised host
    * Cytomegalovirus
    * Pneumocystis jiroveci
    * Aspergillus
    * Candida
{: .notice--info}

### Obstructive Lung Diseases / é–‰å¡æ€§è‚ºç–¾æ‚£
* **Overview**
  * Increase in resistance to airflow
  * Chronic obstructive pulmonary disease: Persistent respiratory symptoms mostly caused by smoking, include emphysema and chronic bronchitis
* **Emphysema**
  * Concept: Enlargement of airspaces and destruction of walls in bronchioles and alveoli
    * Centriacinar: Involve respiratory bronchioles, associated with smoking
    * Panacinar: Involve alveolar ducts and alveoli, associated with Î±1-antitrypsin deficiency
    * Parasetpal: Involve alveoli near septa and pleura, associated with pneumothorax
    * Irregular
  * Pathogenesis: Toxic injury, protease-antiprotease inbalance
  * Morphology: Abnormally large alveoli
  * Clinical: Dyspnea
* **Chronic bronchitis**
  * Concept: Persistent cough with sputum production
  * Pathogenesis: Mucus hypersecretion, CFTR dysfunction
  * Morphology: Reid index (mucous gland thickness / whole layer thickness) increases
  * Clinical: Persistent cough and sputum
* **Asthma**
  * Concept: Chronic airway inflammation, variable airway obstruction
    * Atopic: Triggered by allergens, IgE-mediated hypersensitivity
    * None-atopic: Triggered by virus, pollutants, cold exposure
    * Drug-induced: Triggered by drugs (eg. aspirin)
    * Occupational: Triggered by fumes or chemicals
  * Pathogenesis: TH2 responses, genetic susceptibility, environmental factors
  * Morphology: Increased eosinophils, Charcot-Leyden crystals, Curschmann spirals
  * Clinical: Acute dyspnea and cough, chronic mild cough
* **Bronchiectasis**
  * Concept: Permanent dilation of bronchi and bronchioles
  * Pathogenesis: Persistent infection (eg. tuberculosis), primary ciliary dyskinesia
  * Morphology: Dilated airways
  * Clinical: Severe cough and sputum (sometimes bloody)
{: .notice--info}

### Interstitial Lung Disease / é–“è³ªæ€§è‚ºç–¾æ‚£
* **Overview**
  * Inflammation of interstitium, restrictive lung disease
* **Idiopathic pulmonary fibrosis (Usual interstitial pneumonia)**
  * Concept: Progressive interstitial fibrosis and respiratory failure
  * Pathogenesis: Unknown
  * Morphology: Inhomogeneous in time and space, honeycomb fibrosis
  * Clinical: Gradually increasing dypsnea and dry cough
* **Non-specific interstitial pneumonia**
  * Concept: Often associated with connective tissue disease
  * Morphology: Homogeneous in time and space, cellular or fibrosing pattern
* **Cryptogenic organizing pneomia**
  * Concept: Often associated with infection or injury
  * Morphology: Polyps in alveoli and bronchioles
* **Pulmonary involvement of autoimmune disease**
  * Concept: Involvement of rheumatoid arthritis, systemic sclerosis, or lupus erythematosus
* **Coal worker's pneumoconiosis**
  * Concept: Caused by inhalation of coal particles
  * Morphology: Anthracosis, coal macules and nodules
  * Clinical: Little decrement in lung function
* **Silicosis**
  * Concept: Caused by inhalation of silica
  * Pathogenesis: Silica phagocytosed by macrophages, activate inflammation
  * Morphology: Collagenous nodules
  * Clinical: Varied progression, increase risk of tuberculosis and lung cancer
* **Asbestosis**
  * Concept: Caused by inhalation of asbestos
  * Pathogenesis: Asbestos phagocytosed by macrophages, activate inflammation
  * Morphology: Fibrosis, asbestos bodies
  * Clinical: Late progression, increase risk of lung cancer and mesothelioma
* **Drug-induced lung diseases**
  * Concept: Caused by bleomycin, amiodarone, etc.
* **Radiation-incuded lung diseases**
  * Concept: Caused by radiotherapy
* **Sarcoidosis**
  * Concept: Systemic granulomatous disease
  * Pathogenesis: Unknown
  * Morphology: Non-necrotizing granulomas
  * Clinical: diverse involvement of lung, lymph node, skin, or eye
* **Hypersensitivity pneumonitis**
  * Concept: Caused by inhalation of antigen
  * Pathogenesis: Immunologic
  * Morphology: Non-necrotizing granulomas, inflammatory infiltration
  * Clinical: Fever, cough, dyspnea
* **Pulmonary eosinophilia**
  * Concept: Infiltration of eosinophils
  * Clinical: Fever, cough, dyspnea
* **Desquamative interstitial pneumonia**
  * Concept: Smoking-related
  * Morphology: Accumulation of dusty macrophages in alveoli
* **Respiratory bronchiolitis-associated interstitial lung disease**
  * Concept: Smoking-related
  * Morphology: Accumulation of dusty macrophages in bronchioles
* **Pulmonary Langerhans cell histiocytosis**
  * Concept: Smoking-related
  * Morphology: Collection of grooved Langerhans cells
* **Pulmonary alveolar proteinosis**
  * Concept: Accumulation of surfactant in alveoli
  * Pathogenesis: Defect in macraphages GM-CSF signaling, mostly autoimmune
  * Morphology: Accumulation of eosinophilic precipitate in alveoli
  * Clinical: Cough, sputum, dyspnea
* **Surfactant dysfunction disorders**
  * Concept: Mutation in surfactant-related gene
  * Morphology: Eosinophilic material in alveoli
{: .notice--info}

### Pulmonary Vascular Disorders / è‚ºå¾ªç’°éšœå®³
* **Pulmonary embolism and infarction**
  * Concept: Emboli (usually from deep vein thromboses) occlude pulmonary artery
  * Pathogenesis: In patients with increased tendency to clot
  * Morphology: Large emboli in pulmonary artery, hemorrhagic when infarct
  * Clinical: Dyspnea, chest pain, shock
* **Pulmonary hypertension**
  * Concept: Mean pulmonary artery pressure > 25 mmHg
  * Pathogenesis: Idiopathic (with genetic basis), left heart disease, lung disease or hypoxia, chronic pulmonary emboli
  * Morphology: Hypertropy of pulmonary circulation arteries and right ventricle
  * Clinical: Dyspnea, chest pain, cyanosis, right heart failure
* **Goodpasture syndrome**
  * Concept: Kidney and lung injuries caused by anti-glomerular basement membrane antibody
  * Pathogenesis: Antibodieas against collagen IV Î±3 chain destruct basement membrane in renal glomeruli and pulmonary alveoli
  * Morphology: Hemorrhage, hemosiderin-laden macrophages
  * Clinical: Hemoptysis, glomerulonephritis
* **Pulmonary edema**
  * Concept: Excessive fluid in alveoli, lead to hypoxemia
    * Hemodynamic disturbances: Increased hydrostatic pressure (left-sided heart failure)
    * Microvascular injury: Inflammatory exudate (acute respiratory distress syndrome)
{: .notice--info}

### Lung Tumors / è‚ºè…«ç˜
* **Lung carcinoma**
  * Concept: Malignant tumor from respiratory epithelium
  * Pathogenesis: Exposure to carcinogens leads to accumulation of driver mutations (tobacco smoking, industrial hazards, air pollution)
  * Morphology:
    * Adenocarcinoma: Gland formation, mucin production
    * Squamous cell carcinoma: Keratinization, intercellular bridges
    * Small cell carcinoma: Clusters of small cells
    * Large cell carcinoma: Undifferentiated large cells
  * Clinical:
    * Symptoms: Asymptomatic, cough, chest pain, dyspnea
    * Local effects: Hoarseness, diaphragm paralysis, pleural effusion, SVC syndrome, Pancoast syndrome
    * Paraneoplastic syndromes: SIADH, Cushing syndrome, hypercalcemia, Lambert-Eaton syndrome
* **Carcinoid tumors**
  * Concept: Low-grade malignant tumor from neuroendocrine cells
  * Morphology: Nests of relatively regular cells
  * Clinical: Cough, carcinoid syndrome (intermittent diarrhea and flushing)
* **Miscellaneous tumors**
  * Concept: Benign and malignant mesenchymal tumors
    * Hamartoma: Most common lung benign tumor
    * Lymphangioleiomyomatosis: Mostly in women of childbearing age
    * Inflammatory myofibroblastic tumor: Rare tumor in children
* **Metastatic lung tumors**
  * Concept: Lung is the most common site of metastasis
  * Morphology: Multiple discrete nodules
{: .notice--info}

### Other Lung Disorders / ãã®ä»–ã®è‚ºè‡“ç–¾æ‚£
* **Atelectasis**
  * Concept: Incomplete expansion of lungs. From resorption (obstruction), compression, contraction (fibrosis)
* **Pulmonary hypoplasia**
  * Concept: Defect in lung development
* **Foregut cysts**
  * Concept: Abnormal cysts from foregut
* **Pulmonary sequestration**
  * Concept: Discrete area of lung tissue that (1) is not connected to airways (2) has abnormal blood supply from aorta
* **Acute respiratory distress syndrome**
  * Concept: Abrupt onset of pulmonary edema and hypoxemia, due to increased capillary permeability
  * Pathogenesis: Endothelial activation, neutrophil extravasation, fluid accumulation, hyaline membrane formation. Caused by pneumonia, sepsis, oxegen therapy
  * Morphology: Diffuse alveolar damage, hyaline membranes
  * Clinical: Dyspnea, hypoxemia, bilateral infiltration
* **Lung transplantation**
  * Concept: Transplanted lung is subject to infection and rejection
  * Morphology: Inflammatory infiltrates (acute rejection), bronchiolitis obliterans (chronic rejection)
{: .notice--info}

### Pleural Disorders / èƒ¸è†œç–¾æ‚£
* **Pleural effusion**
  * Concept: Accumulation of fliuds in pleural cavities
    * Inflammatory: From infections, cancers, autoimmune diseases
    * Noninflammatory: From heart failure, renal failure, cirrhosis
* **Pneumothorax**
  * Concept: Gas in pleural cavities. Can be spontaneous, traumatic, therapeutic
* **Solitary fibrous tumor**
  * Concept: Tumor in pleura
  * Morphology: Spindle cells among fibers
* **Malignant mesothelioma**
  * Concept: Malignant tumor in pleural cavities
  * Pathogenesis: Related to asbestos
  * Morphology: Epithelioid, sarcomatoid, biphasic
  * Clinical: Chest pain, dyspnea, pleural effusions
{: .notice--info}

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Infectious Diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Obstructive Lung Diseases / é–‰å¡æ€§è‚ºç–¾æ‚£

## Interstitial Lung Diseases / é–“è³ªæ€§è‚ºç–¾æ‚£

## Immune and Allergic Diseases / å…ç–«ãƒ»ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§ç–¾æ‚£

## Pulmonary Vascular Disorders / è‚ºå¾ªç’°éšœå®³

## Lung Tumors / è‚ºè…«ç˜

## Lungs and Bronchi Abnormalities / è‚ºãƒ»æ°—ç®¡æ”¯ã®å½¢æ…‹ç•°å¸¸

## Functional Respiratory Disorders / æ©Ÿèƒ½çš„å‘¼å¸éšœå®³

## Mediastinal Disorders / ç¸¦éš”ç–¾æ‚£

## Pleural and Chest Wall Disorders / èƒ¸è†œãƒ»èƒ¸å£ç–¾æ‚£

# Renal and Urological / è…ãƒ»æ³Œå°¿å™¨

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Glomerular Disorders / ç³¸çƒä½“ç–¾æ‚£

## Tubulointerstitial Disorders / å°¿ç´°ç®¡ãƒ»é–“è³ªæ€§ç–¾æ‚£

## Renal Disorders with Systemic Diseases / å…¨èº«ç–¾æ‚£ã«ä¼´ã†è…éšœå®³

## Renal Vascular Disorders / è…å¾ªç’°éšœå®³

## Stones and Tumors / çµçŸ³ã¨è…«ç˜

## Infections / æ„ŸæŸ“ç—‡

## Functional Disorders / æ©Ÿèƒ½éšœå®³

## Water and Electrolyte Metabolism Disorders / æ°´ãƒ»é›»è§£è³ªä»£è¬ç•°å¸¸

# Metabolism and Endocrine / ä»£è¬ãƒ»å†…åˆ†æ³Œ

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

### Hypothalamic Hormones / è¦–åºŠä¸‹éƒ¨ãƒ›ãƒ«ãƒ¢ãƒ³
* **Somatostatin analog**
  * Drugs: Octreotide, lanreotide
  * Mechanism:
  * Indications:
  * Toxicities:
* **Gonadotropin-releasing hormone agonist**
  * Drugs: Leuprolide, triptorelin, goserelin, nafarelin, histrelin
  * Mechanism:
  * Indications:
  * Toxicities:
* **Gonadotropin-releasing hormone antagonist**
  * Drugs: Cetrorelix, ganirelix, degarelix
  * Mechanism:
  * Indications:
  * Toxicities:
* **Dopamine agonist**
  * Drugs: Bromocriptine, cabergoline
  * Mechanism:
  * Indications:
  * Toxicities:
{: .notice--info}

### Anterior Pituitary Hormones / ä¸‹å‚ä½“å‰è‘‰ãƒ›ãƒ«ãƒ¢ãƒ³
* **Growth hormone**
  * Drugs: Somatotropin
  * Mechanism:
  * Indications:
  * Toxicities:
* **Growth hormone receptor antagonist**
  * Drugs: Pegvisomant
  * Mechanism:
  * Indications:
  * Toxicities:
* **Follicle-stimulating hormone**
  * Drugs: Urofollitropin, follitropin alfa, menotropins
  * Mechanism:
  * Indications:
  * Toxicities:
* **Human chorionic gonadotropin**
  * Drugs: Human chorionic gonadotropin
  * Mechanism:
  * Indications:
  * Toxicities:
* **Thyroid-stimulating hormone**
  * Drugs: Thyrotropin alfa
  * Mechanism:
  * Indications:
  * Toxicities:
* **Adrenocorticotropic hormone**
  * Drugs: Corticotropin, cosyntropin
  * Mechanism:
  * Indications:
  * Toxicities:
{: .notice--info}

### Posterior Pituitary Hormones / ä¸‹å‚ä½“å¾Œè‘‰ãƒ›ãƒ«ãƒ¢ãƒ³
* **Antidiuretic hormone**
  * Drugs: Vasopressin, desmopressin
  * Mechanism:
  * Indications:
  * Toxicities:
* **Vasopressin receptor antagonist**
  * Drugs: Tolvaptan, conivaptan
  * Mechanism:
  * Indications:
  * Toxicities:
* **Oxytocin**
  * Drugs: Oxytocin
  * Mechanism:
  * Indications:
  * Toxicities:
{: .notice--info}

### Thyroid Hormones / ç”²çŠ¶è…ºãƒ›ãƒ«ãƒ¢ãƒ³
* **Thyroid hormone**
  * Drugs: Levothyroxine, liothyronine
  * Mechanism:
  * Indications:
  * Toxicities:
* **Thioamide**
  * Drugs: Propylthiouracil, methimazole
  * Mechanism:
  * Indications:
  * Toxicities:
* **Iodide**
  * Drugs: Potassium iodide
  * Mechanism:
  * Indications:
  * Toxicities:
* **Radioactive iodine**
  * Drugs: Sodium iodide I-131
  * Mechanism:
  * Indications:
  * Toxicities:
{: .notice--info}

### Glucose Homeostasis / ã‚°ãƒ«ã‚³ãƒ¼ã‚¹æ’å¸¸æ€§
* **Insulin**
  * Drugs:
    * Rapid-acting: Insulin lispro, insulin aspart, insulin glulisine
    * Short-acting: Regular insulin
    * Intermediate-acting: Insulin NPH
    * Long-acting: Insulin glargine, insulin detemir, insulin degludec
  * Mechanism:
  * Indications:
  * Toxicities:
* **Sulfonylurea**
  * Drugs:
    * First-generation: Tolbutamide, chlorpropamide, tolazamide
    * Second-generation: Glyburide, glipizide, glimepiride
  * Mechanism:
  * Indications:
  * Toxicities:
* **Meglitinide**
  * Drugs: Repaglinide, nateglinide
  * Mechanism:
  * Indications:
  * Toxicities:
* **Biguanide**
  * Drugs: Metformin  
  * Mechanism:
  * Indications:
  * Toxicities:
* **Thiazolidinedione**
  * Drugs: Pioglitazone, rosiglitazone
  * Mechanism:
  * Indications:
  * Toxicities:
* **Glucagon-like peptide 1 agonist**
  * Drugs: Exenatide, liraglutide, lixisenatide, albiglutide, dulaglutide
  * Mechanism:
  * Indications:
  * Toxicities:
* **Dipeptidyl peptidase 4 inhibitor**
  * Drugs: Sitagliptin, sazagliptin, linagliptin
  * Mechanism:
  * Indications:
  * Toxicities:
* **Î±-glucosidase inhibitor**
  * Drugs: Acarbose, miglitol
  * Mechanism:
  * Indications:
  * Toxicities:
* **Sodium-glucose cotransporter 2 inhibitor**
  * Drugs: Canaglifozin, empaglifozin, dapaglifozin
  * Mechanism:
  * Indications:
  * Toxicities:
* **Amylin analog**
  * Drugs: Pramlintide
  * Mechanism:
  * Indications:
  * Toxicities:
* **Glucagon**
  * Drugs: Glucagon
  * Mechanism:
  * Indications:
  * Toxicities:
* **Diazoxide**
  * Drugs: Diazoxide
  * Mechanism:
  * Indications:
  * Toxicities:
{: .notice--info}

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Hypothalamus and Pituitary Disorders / è¦–åºŠä¸‹éƒ¨ãƒ»ä¸‹å‚ä½“ç–¾æ‚£

## Thyroid Disorders / ç”²çŠ¶è…ºç–¾æ‚£

## Parathyroid Disorders / å‰¯ç”²çŠ¶è…ºç–¾æ‚£

## Adrenal Gland disorders / å‰¯è…ç–¾æ‚£

## Other Endocrine Disorders / ãã®ä»–ã®å†…åˆ†æ³Œç–¾æ‚£

## Carbohydrate Metabolism Disorders / ç³–è³ªä»£è¬ç•°å¸¸

## Lipid Metabolism Disorders / è„‚è³ªä»£è¬ç•°å¸¸

## Amino Acid Metabolism Disorders / ã‚¢ãƒŸãƒé…¸ä»£è¬ç•°å¸¸

## Other Metabolic Disorders / ãã®ä»–ã®ä»£è¬ç•°å¸¸

## Nutritional Abnormalities / æ „é¤Šã®ç•°å¸¸

# Hematology / è¡€æ¶²

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Red Blood Cell Abnormalities / èµ¤è¡€çƒç³»ã®ç•°å¸¸

## White Blood Cell Abnormalities / ç™½è¡€çƒç³»ã®ç•°å¸¸

## Hemostasis and Coagulation Abnormalities / æ­¢è¡€ãƒ»å‡å›ºç³»ã®ç•°å¸¸

# Immune and Connective Tissue Diseases / å…ç–«ãƒ»è† åŸç—…

## Immunology / å…ç–«å­¦

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

### Adrenocorticosteroids / å‰¯è…çš®è³ªãƒ›ãƒ«ãƒ¢ãƒ³
{: .notice--info}

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Immunodeficiency / å…ç–«ä¸å…¨

## Allergy / ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼

## Connective Tissue Disease / è† åŸç—…

# Infectious Diseases / æ„ŸæŸ“ç—‡

## Microbiology / å¾®ç”Ÿç‰©å­¦

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Bacterial Infections / ç´°èŒæ„ŸæŸ“ç—‡

## Viral Infections / ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡

## Fungal Infections / çœŸèŒæ„ŸæŸ“ç—‡

## Parasitic Infections / å¯„ç”Ÿè™«æ„ŸæŸ“ç—‡

# Neurology / ç¥çµŒ

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Cerebrovascular disorders / è„³è¡€ç®¡ç–¾æ‚£

## Dementia disorders / èªçŸ¥ç—‡æ€§ç–¾æ‚£

## Demyelinating disorders / è„±é«„æ€§ç–¾æ‚£

## Degenerative disorders / å¤‰æ€§ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Muscle disorders / ç­‹ç–¾æ‚£

## Peripheral nerve disorders / æœ«æ¢¢ç¥çµŒç–¾æ‚£

## Functional seizure disorders / æ©Ÿèƒ½æ€§ç™ºä½œæ€§ç–¾æ‚£

## Neurocutaneous syndromes / æ¯æ–‘ç—‡

## Brain tumors / è„³è…«ç˜

## Head injuries / é ­éƒ¨å¤–å‚·

## Malformations / å¥‡å½¢

# Pediatrics / å°å…ç§‘

## Biochemistry / ç”ŸåŒ–å­¦

## Embryology / ç™ºç”Ÿå­¦

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Neonates / æ–°ç”Ÿå…

## Congenital abnormalities / å…ˆå¤©ç•°å¸¸

## Gastrointestinal disorders / æ¶ˆåŒ–å™¨ç–¾æ‚£

## Cardiovascular disorders / å¾ªç’°å™¨ç–¾æ‚£

## Respiratory disorders / å‘¼å¸å™¨ç–¾æ‚£

## Renal and urological disorders / è…ãƒ»æ³Œå°¿å™¨ç–¾æ‚£

## Metabolic and endocrine disorders / ä»£è¬ãƒ»å†…åˆ†æ³Œç–¾æ‚£

## Hematological and hematopoietic disorders / è¡€æ¶²ãƒ»é€ è¡€å™¨ç–¾æ‚£

## Immune and allergic disorders / å…ç–«ãƒ»ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“ç—‡

## Neurological disorders / ç¥çµŒç–¾æ‚£

## Tumors / è…«ç˜

# Gynecology / å©¦äººç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

### Gonadal Hormones /  ç”Ÿæ®–è…ºãƒ›ãƒ«ãƒ¢ãƒ³
* **Estrogen**
  * Drugs: Ethinyl estradiol, mestranol
  * Mechanism:
  * Indications:
  * Toxicities:
* **Selective estrogen receptor modulator**
  * Drugs: Clomiphene
  * Mechanism:
  * Indications:
  * Toxicities:
* **Synthetic androgen**
  * Drugs: Danazol
  * Mechanism:
  * Indications:
  * Toxicities:
* **Progestin**
  * Drugs: Norethidrone, norgestrel, levonorgesterol, megesterol, medroxyprogesterone acetate, hydroxyprogesterone caproate
  * Mechanism:
  * Indications:
  * Toxicities:
* **Antiprogestogen**
  * Drugs: Mifepristone
  * Mechanism:
  * Indications:
  * Toxicities:
{: .notice--info}

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Menstrual abnormalities / æœˆçµŒã®ç•°å¸¸

## Abnormalities in sexual differentiation and genital morphology / æ€§åˆ†åŒ–ã¨æ€§å™¨å½¢æ…‹ã®ç•°å¸¸

## Genital inflammation and sexually transmitted infections / æ€§å™¨ã®ç‚ç—‡ãƒ»æ€§æ„ŸæŸ“ç—‡

## Infertility / ä¸å¦Š

## Age-related changes / åŠ é½¢ã«ä¼´ã†å¤‰åŒ–

## Benign tumors, pre-cancerous lesions, and neoplasms / é¡è…«ç˜ç—…å¤‰ãƒ»å‰ç™Œç—…å¤‰ãƒ»è…«ç˜

## Breast disorders / ä¹³è…ºç–¾æ‚£

# Obstetrics / ç”£ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Abnormalities in pregnancy / å¦Šå¨ ã®ç•°å¸¸

## Complicated pregnancies and mother-child infections / åˆä½µç—‡å¦Šå¨ ãƒ»æ¯å­æ„ŸæŸ“

## Abnormalities in childbirth / åˆ†å¨©ã®ç•°å¸¸

## Postpartum period / ç”£è¤¥

# Urology / æ³Œå°¿å™¨ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†
### Gonadal Hormones /  ç”Ÿæ®–è…ºãƒ›ãƒ«ãƒ¢ãƒ³
* **Androgen**
  * Drugs: Testosterone propionate, testosterone enanthate, testosterone cypionate, methyltestosterone, fluoxmesterone, oxymetholone, nandrolone, oxandrolone
  * Mechanism:
  * Indications:
  * Toxicities:
* **5Î±-reductase inhibitor**
  * Drugs: Finasteride, dutasteride
  * Mechanism:
  * Indications:
  * Toxicities:
{: .notice--info}

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Infections / æ„ŸæŸ“ç—‡

## Tumors / è…«ç˜

## Male Genital Disorders / ç”·æ€§å™¨ç–¾æ‚£

## Sexual Dysfunction / æ€§æ©Ÿèƒ½éšœå®³

# Orthopedics / æ•´å½¢å¤–ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

### Calcium Homeostasis / ã‚«ãƒ«ã‚·ã‚¦ãƒ æ’å¸¸æ€§
{: .notice--info}

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Fractures / éª¨æŠ˜

## Dislocations / è„±è‡¼

## Spinal cord and spinal disorders / è„Šæ¤ãƒ»è„Šé«„ç–¾æ‚£

## Upper limb disorders / ä¸Šè‚¢ã®ç–¾æ‚£

## Lower limb disorders / ä¸‹è‚¢ã®ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Peripheral nerve injuries / æœ«æ¢¢ç¥çµŒæå‚·

## Metabolic bone disorders / ä»£è¬æ€§éª¨ç–¾æ‚£

## Tumors / è…«ç˜

# Ophthalmology / çœ¼ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Refractive and accommodative abnormalities / å±ˆæŠ˜ãƒ»èª¿ç¯€ç•°å¸¸

## Eyelid and lacrimal system disorders / çœ¼ç¼ãƒ»æ¶™å™¨ç–¾æ‚£

## Conjunctival, corneal, and scleral disorders / çµè†œãƒ»è§’è†œãƒ»å¼·è†œç–¾æ‚£

## Uveal disorders / ã¶ã©ã†è†œç–¾æ‚£

## Retinal and vitreous disorders / ç¶²è†œãƒ»ç¡å­ä½“ç–¾æ‚£

## Optic nerve disorders / è¦–ç¥çµŒç–¾æ‚£

## Lens disorders / æ°´æ™¶ä½“ç–¾æ‚£

## Glaucoma / ç·‘å†…éšœ

## Ocular trauma / çœ¼å¤–å‚·

# Otorhinolaryngology / è€³é¼»å’½å–‰ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Inner ear disorders / å†…è€³ç–¾æ‚£

## Middle ear disorders / ä¸­è€³ç–¾æ‚£

## Outer ear disorders / å¤–è€³ç–¾æ‚£

## Neurological disorders / ç¥çµŒç–¾æ‚£

## Nasal and sinus disorders / é¼»è…”ãƒ»å‰¯é¼»è…”ç–¾æ‚£

## Oral, tonsil, and salivary gland disorders / å£è…”ãƒ»æ‰æ¡ƒãƒ»å”¾æ¶²è…ºç–¾æ‚£

## Pharyngeal and laryngeal disorders / å’½é ­ãƒ»å–‰é ­ç–¾æ‚£

# Dermatology / çš®è†šç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Eczema and dermatitis group / æ¹¿ç–¹ãƒ»çš®è†šç‚ç¾¤

## Urticaria and itching group / è•éº»ç–¹ãƒ»æ»ç—’ç¾¤

## Erythema / ç´…æ–‘ç—‡

## Bullous diseases / æ°´ç–±ç—‡

## Pustular diseases / è†¿ç–±ç—‡

## Pigmentation disorders / è‰²ç´ ç•°å¸¸ç—‡

## Nevus / æ¯æ–‘ç—‡

## Keratosis disorders / è§’åŒ–ç•°å¸¸

## Benign tumors / è‰¯æ€§è…«ç˜

## Malignant tumors / æ‚ªæ€§è…«ç˜

## Metabolic disorders / ä»£è¬ç•°å¸¸

# Psychiatry / ç²¾ç¥ç§‘

## Behavior Science / è¡Œå‹•ç§‘å­¦

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Neurotic disorders / ç¥çµŒç—‡æ€§éšœå®³

## Mood disorders and schizophrenia / æ°—åˆ†éšœå®³ãƒ»çµ±åˆå¤±èª¿ç—‡

## Substance-related disorders / ç‰©è³ªé–¢é€£éšœå®³

## Physiological disorders / ç”Ÿç†çš„éšœå®³

## Neurodevelopmental disorders / ç¥çµŒç™ºé”ç—‡ç¾¤

